The Candida IgG test is used to screen for antibodies the body develops in response to Systemic Candidiasis or Candida. Candida is another name for yeast, a fungus which is normally found in small amounts in the body. The immune system normally keeps Candida under control but in cases where a person is sick or taking antibiotics, the yeast may spread, becoming a potentially dangerous infection.
HIV-1 infection results in a decrease of CD4 T cells, an increase of CD8 T cells, a decrease in the CD4:CD8 ratio, and a progressive destruction of immune function. In HIV-1 seropositive patients, enumeration of CD4 T cells may be used for prognostic purposes and to monitor disease progression and antiretroviral therapy.
Also Known As: HIV disease progression & treatment monitoring
C. trachomatis infections are the leading cause of sexually transmitted diseases in the United States. C. trachomatis is known to cause cervicitis, pelvic inflammatory disease (PID), epididymitis and proctitis. It is also the most frequent cause of non-gonococcal urethritis in men. Among women, the consequences of Chlamydial infections are severe if left untreated.
Chlamydia and Gonorrhea are two of the most common contracted STDs. This is a urine test that looks for either Chlamydia and Gonorrhea through nucleic acid amplification.
Neisseria gonorrhoeae may infect the anal/rectal canal of sexually active individuals. Detection of this organism is important for determining the risk for disease progression or transmission.
Also Known As: Urine, pain free
It indicates prior or acute infection with, or immunization to, Hepatitis A virus. Immunoglobulin M (IgM) antibodies to Hepatitis A suggest a current, acute or recent Hepatitis A infection.
The Hepatitis B vaccine is recommended for those who have not been previously vaccinated. This test looks for IgM antibody to hepatitis B core antigen and is a reliable marker for acute hepatitis B infection.
Hepatitis B Virus (HBV) is one of the several viruses that cause hepatitis. HBV PCR test measures the amount of HBV genetic material in the blood.
Also Known As: HBV PCR
Surface antigen usually appears in the serum following exposure to Hepatitis B virus and peaks shortly after onset of symptoms. It typically disappears within 1 to 3 months. Persistence of Hepatitis B surface antigen for greater than 6 months is a prognostic indicator of chronic Hepatitis B infection.
Also Known As: Hepatitis B Immunity Test, Hep B Titer
Surface antigen usually appears in the serum following exposure to Hepatitis B virus and peaks shortly after onset of symptoms. It typically disappears within 1 to 3 months. Persistence of Hepatitis B surface antigen for greater than 6 months is a prognostic indicator of chronic Hepatitis B infection.
Surface antigen usually appears in the serum following exposure to Hepatitis B virus and peaks shortly after onset of symptoms. It typically disappears within 1 to 3 months. Persistence of Hepatitis B surface antigen for greater than 6 months is a prognostic indicator of chronic Hepatitis B infection.
The clinical symptoms of an HCV infection are variable. Infection with HCV results in a chronic infection in 50 to 80% of cases. The window between HCV acquisition and sero-reactivity is highly variable; up to six months.
The clinical symptoms of an HCV infection are variable. Infection with HCV results in a chronic infection in 50 to 80% of cases. The "window" between HCV acquisition and sero-reactivity is highly variable; up to six months.
